Martell J

Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, https://ror.org/041kmwe10Imperial College London, London, UK.

7 papers · ORCID

ArticlePsilocybin

Psilocybin therapy for adult females with anorexia nervosa: pilot study.

Douglass HM, Spriggs MJ, Godfrey K +17

Europe PMC2026
ArticlePsilocybin

Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

O'Connor S, Godfrey K, Reed S +17

Europe PMC2025
ArticlePsilocybin

Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Erritzoe D, Barba T, Greenway KT +9

Europe PMC2024
ArticlePsilocybin

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.

Weiss B, Ginige I, Shannon L +8

Europe PMC2024
ArticleDMT

Human brain effects of DMT assessed via EEG-fMRI.

Timmermann C, Roseman L, Haridas S +12

Europe PMC2023
ArticlePsilocybin

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Murphy R, Kettner H, Zeifman R +10

Europe PMC2021
ArticlePsychedelics

New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy.

Noorani T, Martell J

Europe PMC2021